Tower Research Capital (TRC)’s Omada Health OMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30K Sell
1,443
-7
-0.5% -$155 ﹤0.01% 3536
2026
Q2
$31.8K Sell
1,450
-2,353
-62% -$37.6K ﹤0.01% 3126
2026
Q1
$47.8K Buy
3,803
+1,911
+101% +$26.4K ﹤0.01% 2771
2025
Q4
$29.9K Buy
1,892
+1,124
+146% +$22.8K ﹤0.01% 2811
2025
Q3
$17K Buy
768
+492
+178% +$10.1K ﹤0.01% 3451
2025
Q2
$5.05K Buy
+276
New +$4.78K ﹤0.01% 4232

Other funds holding OMDA

Tower Research Capital (TRC)'s OMDA Position: Q3 2026 in Review

Tower Research Capital (TRC) reduced its Omada Health (OMDA) stake by 0.48% in Q3 2026, selling an estimated $155 and leaving 1,443 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #3536.

Tower Research Capital (TRC) first reported a position in OMDA in Q2 2025 and has held it in 6 quarters since. The position peaked at $47.8K in Q1 2026. 192 funds tracked by Wall St. Rank hold OMDA as of Q3 2026.

  • Tower Research Capital (TRC) held 1,443 shares of Omada Health worth $30K as of Q3 2026.
  • Tower Research Capital (TRC) sold 7 Omada Health shares in Q3 2026, an estimated $155.
  • Omada Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3536 holding.
  • Tower Research Capital (TRC) first reported a position in Omada Health in Q2 2025 and has held it in 6 quarters since.
  • Tower Research Capital (TRC)'s Omada Health position peaked at $47.8K in Q1 2026.
  • 192 funds tracked by Wall St. Rank held Omada Health as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.